#morgan-stanley
West Asia conflict may trigger $800 billion capex boost for India, but oil and fertiliser risks remain: Morgan Stanley
Morgan Stanley’s latest report indicates that geopolitical tensions may boost India’s efforts for supply chain resilience and domestic capacity
Sun Pharma shares rally 9% in two days after $12-bn Organon deal. Here's what Morgan Stanley, other brokerages say
Sun Pharmaceutical Industries' shares surged nearly 9% after announcing the $11.75 billion acquisition of Organon & Co., a global leader in women's health. The deal diversifies Sun Pharma's portfolio into women's health and biosimilars, with analysts from Mor…
Reliance share price target hiked to Rs 1,910: Why Goldman, CLSA, and Morgan Stanley are betting big
Reliance Industries is gaining traction as Goldman Sachs raises its target price, with global brokerages predicting significant upside despite a recent 13% stock dip. Analysts are optimistic about the oil-to-chemicals business recovery, the impending Jio IPO,…